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Abstract
Background: Increasing evidence from epidemiologic studies suggest that oxidative stress may
play a role in adult glioma. In addition to dietary antioxidants, antioxidant and weak estrogenic
properties of dietary phytoestrogens may attenuate oxidative stress. Our hypothesis is that long-
term consumption of dietary antioxidants and phytoestrogens such as genistein, daidzein, biochanin
A, formononetin, matairesinol, secoisolariciresinol and coumestrol, may reduce the risk of adult
glioma.
Methods: Using unconditional logistic regression models, we compared quartiles of consumption
for several specific antioxidants and phytoestrogens among 802 adult glioma cases and 846 controls
from two study series from the San Francisco Bay Area Adult Glioma Study, 1991 – 2000,
controlling for vitamin supplement usage, age, socioeconomic status, gender, ethnicity and total
daily calories. For cases, dietary information was either self-reported or reported by a proxy. For
controls, dietary information was self-reported. Gender- and series- specific quartiles of average
daily nutrient intake, estimated from food-frequency questionnaires, were computed from
controls.
Results: Significant p-values (trend test) were evaluated using significance levels of either 0.05 or
0.003 (the Bonferroni corrected significance level equivalent to 0.05 adjusting for 16 comparisons).
For all cases compared to controls, statistically significant inverse associations were observed for
antioxidant index (p < 0.003), carotenoids (alpha- and beta-carotene combined, p < 0.05), daidzein
(p = 0.003), matairesinol (p < 0.05), secoisolariciresinol (p < 0.003), and coumestrol (p < 0.003).
For self-reported cases compared to controls, statistically significant inverse associations were
observed for antioxidant index (p < 0.05) and daidzein (p < 0.05).
Conclusion: Our results support inverse associations of glioma with higher dietary antioxidant
index and with higher intake of certain phytoestrogens, especially daidzein.
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Background
Epidemiologic evidence from studies of dietary antioxi-
dant intake and adult glioma support a role for oxidative
stress in gliomagenesis. Several studies have shown that
antioxidant consumption from fruits and vegetables may
be protective against adult glioma [1-4]. Most recently, a
large case-control study in Nebraska showed that
increased intake of carotenoids reduces the risk of glioma
by 50 percent and suggests that antioxidant as well as phy-
tochemical nutrient intake is likely to play a protective
role in adult glioma [4]. Pro-inflammatory and pro-ang-
iogenic mediators may also be implicated in glioma
development and progression. Recent studies suggest that
estrogen receptors may play a role in decreasing both pro-
inflammatory and pro-angiogenic mediators [5,6]. Fur-
thermore, estrogen receptor expression is negatively corre-
lated with astrocytic tumor grade [7]. Phytoestrogens,
plant-derived chemicals with both antioxidative and
estrogenic properties, have structural similarities to 17-
beta-estradiol and can be categorized to isoflavones (eg.,
genistein, daidzein, biochanin A, and formononetin), lig-
nans (eg., matairesinol and secoisolariciresinol), and cou-
mestans (eg., coumestrol). Some foods rich in isoflavones
include soy, lentils, and beans. Foods rich in lignans
include oilseeds, whole-grain cereals, legumes, and ber-
ries; while alfalfa and clover are foods rich in coumestans.
In addition to their antioxidative and estrogenic proper-
ties, phytoestrogens are noted for their clinical potential
in antiviral, antibacterial, antiproliferative, angiogenic
activities [8].
If oxidative stress is involved in brain tumor development,
then dietary intake of nutrients of fruits and vegetables
with antioxidative and estrogenic properties may reduce
the risk of adult glioma. We addressed this hypothesis by
comparing nutrient intake between incident glioma cases
and controls of the San Francisco Bay Area Adult Glioma
Study, 1991–2000.
Methods
Human subject methods were approved by the University
of California Committee on Human Research, approval
number H6539-04956. Informed consent was docu-
mented through subject signature on the approved con-
sent document.
Case ascertainment
The San Francisco Bay Area Adult Glioma Study, 1991–
2000, is described in detail elsewhere [2,9-12]. Briefly,
cases were identified within a median of seven weeks of
diagnosis using Northern California Cancer Center's rapid
case ascertainment system. Eligible cases included those
age 20 years and older, with histologically confirmed
newly diagnosed glioma, International Classification of
Disease for Oncology codes 9380 to 9481, who resided in
6-counties of the San Francisco Bay Area, which included
Alameda, Contra Costa, Marin, San Mateo, San Francisco,
or Santa Clara. Ascertainment periods included August
1991 to April 1994 (series 1) and from May 1997 to
August 2000 (series II). Pathologic specimens were
obtained and reviewed by a single neuropathologist in
each series [13,14], thereby minimizing misclassification
of diagnosis.
Control ascertainment
In both series, controls were identified by random digit-
dialing and frequency matched to cases on ten-year age
groups, gender, and ethnicity (White, Black, Hispanic,
Asian, or other). Initial sampling units included area code,
3-digit prefix, and 2 digits of cases' phone numbers. Eligi-
ble matches were found for each sampling unit through 2
digit suffixes generated from random number tables [2].
Dietary questionnaires and interviews
Series I
Eligible cases or next-of-kin and controls were sent a letter
and telephoned to schedule an in-person interview at sub-
jects' home or other location of their choice [2]. Inter-
views were conducted with consenting subjects or their
next-of-kin (proxies) when cases were not available due to
death or disability. Subjects were sent a self-administered
dietary questionnaire in advance, which was collected or
completed at the in-person interview. All questions were
asked for the year prior to glioma diagnosis for cases and
for the previous year for controls.
The series I questionnaire consisted of 79-item food-fre-
quency questions modified from the US National Cancer
Institutes' (Block's) Health Habits and History Question-
naire [15] and the Los Angeles Glioma and Meningioma
Study Questionnaire [16]. The modifications were origi-
nally made to emphasize antioxidant, nitrite, and nitrate
– containing foods [2]. Food items were group into the
following categories: fruits and juices; vegetables; break-
fast foods; lunch foods; meat, fish, poultry and mixed
dishes; breads, salty snacks and spreads; sweets; dairy
products and beverages. Participants were asked to choose
usual frequencies of consumption of each food item. The
frequency choices included: 'never', 'less than 1 per
month', '1 per month', '2–3 per month', '1 per week', '2
per week', '3–4 per week', '5–6 per week', '1 per day', and
'2 or more per day'. Portion sizes were not asked, but were
estimated using gender- and age- specific values from the
Block and colleagues' National Cancer Institute's Health
Habits and History Questionnaire [15]. Additional ques-
tions were asked about how often lemon juice was added
to fish, fruit juices or tea was consumed with cured meat
or bacon, and beer was consumed with meals. Frequency
of vitamin supplement use (never or number of times per
day, week, month, or year as well as dose) was also asked.BMC Cancer 2006, 6:148 http://www.biomedcentral.com/1471-2407/6/148
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Series II
Similarly, eligible cases or next-of-kin and controls were
sent a letter and telephoned to schedule an in-person
interview at subjects' home or other location of their
choice. Interviews were conducted with consenting sub-
jects or their proxies when cases were not available due to
death or disability. Rather than a self-administered diet
questionnaire as in series I, interviewers asked the diet
questions in series II. As in series I, all questions were
asked for the year prior to glioma diagnosis for cases and
for the previous year for controls in series II.
The series II diet questionnaire consisted of 96 food-fre-
quency questions modified from the US National Cancer
Institutes' (Block's) Health Habits and History Question-
naire [15] and included questions on portion sizes. Mod-
ifications included additional fruits, vegetables, and soy
products (eg., avocado, banana, fresh peaches, mangoes
or papayas, beets, cauliflower, celery, turnips, radishes,
rhubarb, salsa, soy burgers, soy milk, and, tofu). The fre-
quency choices included: 'never or less than 1 per month',
'1 per month', '2–3 per month, '1 per week', '2 per week',
'3–4 per week', '5–6 per week', '1 per day'. Portion sizes
were asked according to the number of pieces, or either
small, medium, large, or extra-large, for food frequencies
of 1 per week or greater; using visual aids and 3-dimen-
sional models. Questions on type (multi-vitamin or anti-
oxidant), frequency and duration of vitamin supplements
usage were also included.
Series I & II
For the purposes of assessing major differences of dietary
consumption comparing eligible participants to eligible
non-participants, an abbreviated questionnaire was
administered to some unwilling to participate in the full
interview. In a 5-minute phone interview, the abbreviated
questionnaire asked basic demographic and dietary
(including vitamin supplement use) questions.
Dietary analyses
For both series, only one value was assigned for each food
frequency choice by converting the unit of year, month or
day to the number of times per day. For ranges of frequen-
cies, the mid-value was assigned before conversion, e.g.
2.5 times per month was assigned if the '2–3 per month'
category was given. Intake of each food item was con-
verted to grams consumed per day by applying an appro-
priate algorithm for each series as described in the
following: For series I, the frequency and an assigned gen-
der- and age-specific medium portion size were multi-
plied against a nutrient database to produce grams
consumed per day for each food item. The assigned gen-
der- and age-specific medium portions were based on the
Block and colleagues' National Cancer Institute's Health
Habits and History Questionnaire Personal Computer
System Packet [17]. For series II, the frequency and por-
tion reported were multiplied against the same nutrient
database to produce grams consumed per day for each
food item. For both series, this nutrient database, which
included a total of 27 nutrients per 100 grams for each
food item, was based on the California Teacher's Study
[18,19], USDA nutrient database [20], and the Block and
colleagues' National Cancer Institute's Health Habits and
History Questionnaire Personal Computer System Packet
[17]. The summation of nutrient amounts over all food
items provided a subject's total daily intake for 27 nutri-
ents. Of the 27 nutrients, there was a total of 15 antioxi-
dants and phytoestrogens for our case-control
comparisons.
Additionally for both series, a total daily antioxidant
index intake was calculated by summing the product of
grams consumed over all food items and units of antioxi-
dant index per gram from an antioxidant index database
for fruit, vegetable, juice and tea food items. We con-
structed the antioxidant index database based on data
from Wang and colleagues [21] (for fruits and fruit juices),
Cao and colleagues [22] (for fruits and vegetables) and
Rice-Evans and Miller [23] (for fruits, vegetables, and
teas). A total of 35 items of fruits, vegetables, juices and
teas from either series were included in the antioxidant
index database. All 35 food items were available for series
II participants, while only 22 of the 35 food items were
available for series I participants (see above for additional
fruits and vegetables included in series II only). Therefore,
because the antioxidant index was the sum of antioxidant
values across food items reportedly consumed by each
subject, series II participants had higher values for the
total antioxidant index than series I participants. Antioxi-
dant index values were units of micromoles Trolox equiv-
alents per gram of food (fruits, vegetables, juices or teas).
Trolox equivalents per gram of food were measured by the
oxygen radical absorbance capacity (ORAC) assay [21,22].
The ORAC assay measures the degree to which a sample
inhibits oxidizing agent action using Trolox, a water-solu-
ble analogue of vitamin E, as a control standard.
SAS version 8.02 (SAS Institute Inc, Cary, NC) was used
for all statistical analyses. Demographic distributions of
cases were compared to those of controls using t-tests or
analysis of variance (ANOVA) for continuous variables
and chi-square tests for categorical variables. Means and
standard errors as well as geometric means with upper and
lower 95% confidence limits for daily consumption of
total antioxidant index as well as various individual anti-
oxidants and phytoestrogens adjusted for total calories
were generated with general linear models for all cases,
self-reporting cases and controls using SAS procedure
GLM. Logistic regression models estimated odds ratios for
quartiles of consumption of antioxidant index or eachBMC Cancer 2006, 6:148 http://www.biomedcentral.com/1471-2407/6/148
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nutrient adjusting for age (continuous), gender, ethnicity
(White versus other), socioeconomic status (combined
income and education categories), and total calories (con-
tinuous). Thus, to adjust for total energy intake, we
employed the standard multivariate method [24]. In addi-
tion, vitamin supplement use and/or meat consumption
were explored as covariates in the logistic regression mod-
els.
Case-control comparisons were analyzed separately by
series since data on nutrient and antioxidant index intake
was collected by different methods between study series.
Because comparison of series-specific odds ratios and cor-
responding 95% confidence showed that odds ratios were
largely in the same direction and their corresponding 95%
confidence intervals overlapped between series, we also
conducted combined series case-control comparisons
with a study series indicator variable as a necessary covari-
ate in logistic regression models. Gender- and series- spe-
cific quartile cutpoints were determined for the
antioxidant index or nutrient intake levels based on food
consumption among the controls. Test for trend were
computed for case-control odds ratios of antioxidant
index or nutrient quartiles. Results are described for p-val-
ues generated based on a 5% significance level and two-
sided hypothesis tests. Finally, a Bonferroni correction for
16 simultaneous comparisons (an antioxidant index plus
15 nutrients) was applied to emphasize results based on a
0.003 (= 0.05/16) significance level.
Results
The total number of subjects from both series that were
identified as eligible to participate in the San Francisco
Bay Area Adult Glioma Study, 1991–2000, includes 1,110
cases and 1,284 controls. Participation was greater among
eligible cases (79%–80% for series I and II) than among
eligible controls (67% for combined series data, 74% for
series I, and 60% for series II) [9-11]. Dietary data for 98
percent (846/864) of controls, 94 (497/524) percent of
self-reported cases and 87 (305/349) percent of proxy-
reported cases were included in the dietary analyses, based
on the number of items with missing food frequency and
daily intake of total calories. Table 1 summarizes fre-
quency distributions for vitamin supplement intake,
demographics, and clinical factors for 802 cases (includ-
ing responses from 305 proxies and 497 self-reporting
cases) and 846 controls included in the dietary analyses.
Because of better survival of younger cases, the mean age
for self-reported cases was 50 years, significantly lower
than that of the controls (p < 0.001, table 1). For com-
bined income and education, self-reported cases had
greater socioeconomic status than controls (p < 0.001,
table 1); likely due to younger ages of self-reporting cases.
Geometric means of total daily nutrients consumed
adjusted for total calories among cases and controls are
shown in table 2. The observed average daily nutrients
consumed were reasonable values for the U.S.
Information on vitamin type (multi-vitamin or antioxi-
dant), asked for series II, was not considered during the
analyses because the reported data did not appear to
reflect a reasonable distribution of supplement types. In
addition, differential absorption rates between supple-
ments and foods prevent the combination of nutrients
from supplement types with that from foods consumed.
Therefore, all vitamin supplement analyses only consid-
ered intake (yes or no). Results of an abbreviated diet
questionnaire for comparisons of participants and non-
participants, showed that vitamin use among controls
adjusted for age, gender, and ethnicity was similar for par-
ticipants and non-participants (OR = 1.3, 95% CI = 0.91
to 1.82; data not shown). Interestingly, the percent of
cases (among all and self-reported cases) that regularly
consumed vitamin supplements was significantly lower
than that of controls (p < 0.001, table 1). Regardless of
study series, a significantly lower percentage of cases
(either all or self-reported) than controls reported use of
vitamin supplements (p = 0.002 and p = 0.005 for series I
and II, respectively; data not shown). For this reason, we
also compared case-control nutrient consumption strati-
fied by vitamin supplement use and observed a high
degree of overlap among 95% confidence intervals of
odds ratios across strata (data not shown).
Age- gender-, ethnicity-, socioeconomic status-, and sup-
plement intake-adjusted odds ratios for quartiles of total
calories consumed are shown in table 3. Case-control
odds ratios for quartiles of nutrient intakes adjusted for
age, gender, ethnicity, socioeconomic status, total calo-
ries, and supplement intake are shown in tables 4 and 5.
Case-control distributions (= N) for quartiles of nutrient
consumption are provided in supplemental table 1 [see
Additional file 1]. Examining these results for those that
were statistically significant and consistent for all cases
versus controls and self-reported cases versus controls, we
found that odds ratios for intakes of antioxidant index,
carotenoids (alpha- and beta-carotene combined), and
the phytoestrogens, daidzein, and matairesinol were
reduced (tables 4 and 5). Although not consistent with
self-reported cases compared to controls, other notable
findings regarding nutrient intake include statistically sig-
nificant differences among all cases compared to controls,
which include consumption of vitamin C, and the phy-
toestrogens, genistein, formononetin, secoisolariciresinol
and coumestrol (table 4). After applying a Bonferroni cor-
rection, statistically significant p-values for trend tests
were observed for all cases compared to controls among
combined series data for antioxidant index (p = 0.002),
daidzein (p = 0.003), secoisolariciresinol (p = 0.001) and
coumestrol (p = 0.001). Additionally, after adjustment forBMC Cancer 2006, 6:148 http://www.biomedcentral.com/1471-2407/6/148
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Table 1: Distribution of vitamin supplement intake, age, gender, ethnicity, income, education, body mass index and tumor type for 
eligible participants for combined series I & II; San Francisco Bay Area Adult Glioma Study, 1991–2000
Description Cases1
Controls (N = 
846)
All (N = 802) Self-reported (N = 497) Proxy-reported (N = 305)
Vitamin 
Supplement 
intake (% YES)
62.6 52.4 *** 50.2 *** 56.0 *
General 
Demographics
Age (median) 
± SE2
55.1 ± 0.6 55.4 ± 0.6 ns 49.7 ± 0.7 *** 64.7 ± 0.8 ***
Gender as % 
Male
54.5 57.1 ns 58.6 ns 54.8 ns
Ethnicity as 
% White3
83.8 83.3 ns 83.9 ns 82.3 ns
Socio-economic 
Status Measures 
(%)
Household 
Income4
<$29,999 25.0 24.3 ns 17.4 *** 36.0 ***
$30,000–
$69,999
40.8 39.8 38.5 42.1
≥$70,000 34.1 35.9 44.1 21.9
Highest 
Education
Less than 
high 
school
6.0 10.1 ** 4.8 ns 18.7 ***
High 
school, 
some 
college
48.5 48.9 47.5 51.2
College 
graduate 
and/or 
more
45.5 41.0 47.7 30.2
Socio-economic 
Status5
<High 
School 
education or 
income 
<$29,999
27.3 27.7 ns 19.1 *** 41.6 ***
≥High 
School 
graduate or 
income 
$30,000–
$69,999
53.2 50.4 52.7 46.6
College 
graduate and 
income ≥ 
$70,000
19.5 22.0 28.2 11.8
Body Mass 
Index6 (median) 
± SE2
25.7 ± 0.2 25.9 ± 0.2 ns 25.7 ± 0.2 ns 26.2 ± 0.3 ns
Tumors 
Types (%)
Glioblasto
ma
59.2 47.7 78.0BMC Cancer 2006, 6:148 http://www.biomedcentral.com/1471-2407/6/148
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meat consumption, the only noteworthy changes were for
vitamin C consumption. Consumption of vitamin C for
cases was no longer significantly different than that of
controls after adjusting for meat consumption (OR = 0.77,
95% CI = 0.58 to 1.02, for second quartile compared to
lowest; OR = 0.78, 95% CI = 0.59 to 1.05, for third quar-
tile compared to lowest; OR = 0.76, 95% CI = 0.56 to 1.04,
for highest quartile compared to lowest; combined series
I and II for all cases compared to controls). The effect of
adjustment for meat consumption was negligible for all
other dietary variables.
Discussion
We previously discussed in detail major potential sources
of bias in these case-control dietary data [2]. Briefly, bias
could result from differential data quality between proxy
and self-reported dietary histories with more accurate data
from self-reports. Differential participation of controls
who are more health conscious and therefore might eat
foods that are considered to be healthier such as fruits and
vegetables could also bias results. In addition, the dietary
data collected may not accurately represent actual dietary
data during the etiologically relevant period of brain
tumor development; however, this etiologically relevant
Anaplastic 
Astrocyto
ma
11.2 10.7 12.1
Astrocyto
ma
5.4 7.2 2.3
Oligoden
droglioma
11.1 16.5 2.3
Oligoastr
ocytoma
6.2 8.5 2.6
Ependym
oma
1.0 1.4 0.3
Other 5.9 8.1 2.3
1 p-values for case-control comparisons (t-tests for continuous variables or chi-square tests for categorical variables): * p = 0.05, **p = 0.01, ***p = 
0.001, or not significant (ns). 2 SE = standard error. 3 The category other than white includes African-Americans, Chinese, Japanese, other Asians, 
Filipinos, Mexicans, other Latinos, and others. 4 Percentages do not total 100% due to "Refuse to Answer" and "Don't Know". 5 Categories for 
Socio-economic Status combine highest education attained and/or household income range. 6 BMI calculated from reported height and weight at 
interview.
Table 1: Distribution of vitamin supplement intake, age, gender, ethnicity, income, education, body mass index and tumor type for 
eligible participants for combined series I & II; San Francisco Bay Area Adult Glioma Study, 1991–2000 (Continued)
Table 2: Geometric means of consumption of daily nutrients adjusted for total calories*; San Francisco Bay Area Adult Glioma Study, 
1991–2000.
NUTRIENT Controls (N = 846) All Cases (N = 802) Self-reported Cases (N = 497)
Antioxidant index1 2675.3 2433.3 2450.4
Vitamin E (mg) 7.8 7.7 7.6
Vitamin C (mg) 115.8 107.6 109.6
Carotenoids2 (mcg) 3743.3 3404.0 3327.1
Alpha-carotene (mcg) 672.6 581.4 554.6
Beta-carotene (mcg) 3008.8 2756.0 2697.7
Lutein (mcg) 2094.3 1884.7 1911.4
Lycopene (mcg) 1324.4 1310.6 1320.9
Cryptoxanthin (mcg) 114.1 106.7 111.0
Phytoestrogens:
Formononetin (mcg) 14.7 14.2 15.2
Coumestrol (mcg) 121.1 107.9 112.1
Matairesinol (mcg) 25.3 23.3 23.6
Genistein (mcg) 260.4 233.5 253.9
Daidzein (mcg) 396.9 352.7 372.8
Biochanin A (mcg) 25.4 23.5 24.0
Secoisolariciresinol (mcg) 115.0 104.1 103.5
Total Protein (g) 60.9 59.7 59.2
Total Fat (g) 56.4 58.2 56.8
Total Cholesterol (mg) 200.7 210.2 204.7
Total Kcal (unadjusted) 1609.6 1646.5 1612.7
1Units are daily micromoles of Trolox equivalents gram of fresh weight as determined by the oxygen radical absorbance capacity (ORAC) assay. 2 
alpha- and beta-Carotene. *Note: Means within each group were adjusted for total calories.BMC Cancer 2006, 6:148 http://www.biomedcentral.com/1471-2407/6/148
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time period is unknown. For this reason, the period of die-
tary recall was limited to recent dietary habits to improve
recall accuracy. Furthermore, non-differential dietary mis-
classification may affect series I data as a result of using
computed measures of dietary nutrients because these
computations assume consumption of average portion
sizes for age group and gender specific subjects, which
may decrease detectable differences in nutrient consump-
tion. This issue is likely to be overcome in series II data,
which ascertained portion sizes for foods consumed once
a week or more. Also, since actual nutrient values of foods
depend on soil quality and other factors, the nutrient
database values used in these analyses may either over or
underestimate the actual nutrients of the foods con-
sumed. Since, to our knowledge, this is the first study to
investigate an association between antioxidant index of
foods consumed with a disease, we used estimates for
antioxidant values based solely on literature review. Our
findings of an inverse association between antioxidant
index and glioma may encourage other researchers to fur-
ther investigate these antioxidant indices and their physi-
ologic relevance. In addition, since the series I food-
frequency questionnaire lacked some foods with high
quantities of phytoestrogens (such as tofu and soy, which
are both high in genistein and daidzein), the estimated
daily intake of such phytoestrogens are likely lower than
actual values. While the series II food-frequency question-
naire included these additional food items that are likely
to more accurately assess total intakes of phytoestrogens,
evidence of an association is strong in both series data for
nutrients driven largely by soy products (especially daid-
zein). Therefore, we are encouraged that we likely have an
overall improved assessment of phytoestrogen intake with
consideration of series II data. It should also be noted that
individual variability is likely to contribute to differences
in metabolism and bioavailability of dietary phytoestro-
gens [25]. Regarding the validity of the estimates of nutri-
ents consumed for the food-frequency information
assessed in this study, both antioxidant [26] and phytoes-
trogen (Horn-Ross, P. et al., Am J Epidemiol, in review,
2005) nutrients estimates closely approximate reference
values in previous studies. Finally, although we report
findings that were statistically significant at the 0.05 level,
because of multiple comparisons, the actual p-values are
likely to be higher than those calculated. For this reason,
we also emphasize statistically significant results at the
0.003 level after applying a Bonferroni correction for 16
simultaneous comparisons.
Due to methodological differences in data collection
between series, we presented the data separately by series.
Because the direction and 95% confidence limits of odds
ratios were similar across series, we also performed com-
bined series analyses since increasing the sample size
increases the power to detect statistically significant find-
ings. It should be noted that our combined series analysis
Table 3: Odds ratios for cases versus controls by quartiles of total calories adjusted for age, gender, ethnicity, SES*, and supplement 
use; San Francisco Bay Area Adult Glioma Study, 1991–2000.†
Quar-
tiles of 
Total 
Calorie
s2
Combined Series I & II1 Series I (1991–1995) Series II (1996–2000)
OR 95% CI3 p4 OR 95% CI3 p4 OR 95% CI3 p4
All 
case-
control
1st 1 -- -- 1 -- -- 1 -- --
2nd 1.27 0.87 1.84 0.51 1.49 0.87 2.54 0.45 1.07 0.63 1.82 0.93
3rd 1.15 0.70 1.90 1.41 0.69 2.88 0.93 0.46 1.90
4th 1.47 0.72 3.02 1.79 0.65 4.97 1.21 0.43 3.39
Self-
reporte
d case-
control
1st 1 -- -- 1 -- -- 1 -- --
2nd 1.22 0.79 1.87 0.74 1.62 0.84 3.11 0.53 0.98 0.55 1.76 0.83
3rd 1.11 0.62 1.99 1.59 0.66 3.83 0.82 0.37 1.80
4th 1.30 0.56 2.99 1.79 0.51 6.23 1.03 0.32 3.26
*Categories for socio-economic status (SES) combine highest education attained and/or household income range. †Case-control distributions (= N) 
for quartiles of nutrient consumption are provided in supplemental table 1 [see Additional file 1]. 1Also adjusted for study series.2Quartile cutpoints 
were calculated from series- and gender-specific nutrient intake distributions among controls. 3CI = Confidence interval. 4 p-value for chi-square 
test for trend.BMC Cancer 2006, 6:148 http://www.biomedcentral.com/1471-2407/6/148
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Table 4: Odds ratios for all glioma cases versus controls by quartiles of daily nutrient intake adjusted for age, gender, ethnicity, SES*, 
total calories**, and supplement use; San Francisco Bay Area Adult Glioma Study, 1991–2000.†
Nutri-
ent 
Quartil
e2
Combined Series I & II1 Series I (1991–1995) Series II (1996–2000)
OR 95% CI3 p4 OR 95% CI3 p4 OR 95% CI3 p4
Antioxi
dant 
Index
1st 1 -- -- 0.002 1- -- - 0.004 1 -- -- 0.12
2nd 0.81 0.61 1.07 0.82 0.56 1.20 0.79 0.53 1.20
3rd 0.82 0.62 1.09 0.77 0.52 1.14 0.89 0.59 1.35
4th 0.57 0.42 0.78 0.52 0.33 0.79 0.64 0.40 1.03
Vitami
n E
1st 1 -- -- 0.45 1 -- -- 0.46 1 -- -- 0.06
2nd 0.95 0.71 1.27 1.12 0.74 1.69 0.80 0.53 1.22
3rd 0.79 0.57 1.10 1.02 0.64 1.62 0.60 0.37 0.96
4th 0.91 0.62 1.34 1.28 0.75 2.19 0.62 0.35 1.09
Vitami
n C
1st 1 -- -- 0.02 1- -- - 0.03 1 -- -- 0.31
2nd 0.74 0.56 0.97 0.75 0.51 1.09 0.72 0.48 1.09
3rd 0.73 0.55 0.97 0.71 0.48 1.05 0.75 0.49 1.14
4th 0.70 0.51 0.94 0.63 0.41 0.95 0.78 0.50 1.23
Carote
noids5
1st 1 -- -- 0.02 1- -- - 0 . 2 3 1- -- - 0.03
2nd 0.72 0.54 0.95 0.73 0.49 1.08 0.71 0.48 1.06
3rd 0.84 0.63 1.11 0.93 0.64 1.37 0.74 0.49 1.11
4th 0.65 0.48 0.88 0.70 0.46 1.06 0.60 0.39 0.93
α-
Carote
ne
1st 1 -- -- 0.07 1 -- -- 0.46 1 -- -- 0.07
2nd 0.87 0.66 1.15 1.03 0.70 1.52 0.73 0.49 1.09
3rd 0.83 0.63 1.10 1.06 0.72 1.58 0.64 0.42 0.96
4th 0.76 0.57 1.02 0.83 0.55 1.27 0.71 0.47 1.08
β-
Carote
ne
1st 1 -- -- 0.04 1- -- - 0 . 2 4 1- -- - 0 . 0 9
2nd 0.79 0.60 1.04 0.73 0.49 1.08 0.85 0.58 1.27
3rd 0.79 0.59 1.05 0.86 0.58 1.27 0.70 0.46 1.06
4th 0.72 0.54 0.98 0.73 0.48 1.10 0.72 0.47 1.11
Lutein
1st 1 -- -- 0.06 1 -- -- 0.05 1 -- -- 0.55
2nd 1.02 0.78 1.34 1.17 0.81 1.70 0.86 0.57 1.29
3rd 0.86 0.65 1.14 0.88 0.60 1.30 0.85 0.56 1.28
4th 0.79 0.59 1.05 0.71 0.47 1.07 0.88 0.58 1.33
Lycope
ne
1st 1 -- -- 0.75 1 -- -- 0.98 1 -- -- 0.69
2nd 0.91 0.69 1.21 0.99 0.67 1.46 0.83 0.55 1.25
3rd 1.01 0.76 1.33 1.05 0.72 1.55 0.96 0.63 1.45
4th 1.02 0.76 1.36 0.98 0.66 1.48 1.05 0.68 1.60
Crypto
xanthin
1st 1 -- -- 0.08 1 -- -- 0.12 1 -- -- 0.39
2nd 0.96 0.73 1.26 0.76 0.52 1.11 1.26 0.84 1.88
3rd 0.92 0.69 1.21 0.86 0.59 1.26 1.00 0.65 1.52BMC Cancer 2006, 6:148 http://www.biomedcentral.com/1471-2407/6/148
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is similar to a meta-analysis, a common epidemiologic
practice, with the advantage of having the raw data to
directly estimate associations from the combined data.
Combined series odds ratios were generated with addition
of a series indicator covariate in the logistic regression
models. Additionally, because of the many limitations
with retrospective dietary assessment, we focus on results
that were reasonably consistent in magnitude and statisti-
cal significance between all cases versus controls and self-
reporting cases versus controls. For those nutrients with
such consistent findings, the odds ratios for highest to
lowest quartiles of intake tended to be further from the
null among subjects without reported supplement use
than those with such use. These findings could indicate
that distributions of dietary choices of people taking sup-
plements are more similar regardless of case-status.
Despite the many caveats inherent in retrospective dietary
assessment, our findings, in light of previous epidemio-
logic and mechanistic studies, support the growing evi-
4th 0.77 0.57 1.03 0.69 0.46 1.02 0.88 0.56 1.38
Geniste
in
1st 1 -- -- 0.06 1 -- -- 0.20 1 -- -- 0.11
2nd 0.77 0.58 1.02 0.65 0.43 0.97 0.90 0.60 1.35
3rd 0.71 0.52 0.96 0.56 0.36 0.87 0.89 0.58 1.36
4th 0.74 0.54 1.02 0.74 0.45 1.20 0.68 0.44 1.06
Daidzei
n
1st 1 -- -- 0.003 1- -- - 0 . 3 0 1- -- - 0.0006
2nd 0.77 0.58 1.01 0.96 0.65 1.41 0.60 0.40 0.90
3rd 0.61 0.46 0.82 0.65 0.43 0.98 0.56 0.37 0.86
4th 0.67 0.50 0.90 0.90 0.59 1.38 0.47 0.30 0.72
Biocha
nin A
1st 1 -- -- 0.10 1 -- -- 0.04 1 -- -- 0.84
2nd 0.84 0.63 1.11 0.64 0.43 0.95 1.12 0.75 1.68
3rd 0.77 0.58 1.02 0.71 0.48 1.05 0.82 0.54 1.26
4th 0.79 0.59 1.07 0.61 0.40 0.92 1.06 0.69 1.65
Formo
nonetin
1st 1 -- -- 0.58 1 -- -- 0.58 1 -- -- 0.81
2nd 0.76 0.57 1.00 0.73 0.50 1.08 0.78 0.52 1.18
3rd 0.69 0.52 0.92 0.63 0.42 0.93 0.77 0.51 1.17
4th 0.95 0.72 1.27 0.94 0.64 1.39 0.96 0.63 1.47
Mataire
sinol
1st 1 -- -- 0.03 1- -- - 0.01 1 -- -- 0.60
2nd 0.74 0.56 0.98 0.59 0.40 0.86 0.95 0.64 1.42
3rd 0.80 0.60 1.06 0.78 0.54 1.15 0.80 0.53 1.22
4th 0.68 0.50 0.92 0.50 0.33 0.77 0.93 0.60 1.46
Secoiso
larici-
resinol
1st 1 -- -- 0.001 1- -- - 0.03 1- -- - 0.003
2nd 1.01 0.77 1.33 0.74 0.50 1.08 1.37 0.93 2.03
3rd 0.81 0.61 1.08 0.80 0.55 1.17 0.80 0.52 1.23
4th 0.60 0.44 0.82 0.60 0.40 0.92 0.57 0.35 0.91
Coume
strol
1st 1 -- -- 0.001 1- -- - 0.01 1- -- - 0.02
2nd 0.71 0.54 0.94 0.73 0.49 1.07 0.68 0.45 1.01
3rd 0.62 0.46 0.83 0.60 0.40 0.90 0.62 0.41 0.94
4th 0.59 0.43 0.80 0.57 0.37 0.88 0.59 0.37 0.93
*Categories for socio-economic status (SES) combine highest education attained and/or household income range. **Total calories = ln(total 
calories). †Case-control distributions (= N) for quartiles of nutrient consumption are provided in supplemental table 1 [see Additional file 1]. 1Also 
adjusted for study series. 2Quartile cutpoints were calculated from series- and gender-specific nutrient intake distributions among controls. 3CI = 
Confidence interval. 4 p-value for chi-square test for trend. 5 alpha- and beta-Carotene. Note: Boxed values are statistically significant odds ratios 
(with corresponding 95% confidence intervals that exclude 1.00) or tests for trend.
Table 4: Odds ratios for all glioma cases versus controls by quartiles of daily nutrient intake adjusted for age, gender, ethnicity, SES*, 
total calories**, and supplement use; San Francisco Bay Area Adult Glioma Study, 1991–2000.† (Continued)BMC Cancer 2006, 6:148 http://www.biomedcentral.com/1471-2407/6/148
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dence of a role for oxidative stress in adult glioma.
Vitamin C is a water soluble, well known scavenger of
hydroxyl radicals that inhibits oxidative DNA lesions such
as 8-hydroxydeoxyguanosine [27]. We observed an
inverse association with adult glioma for vitamin C con-
sumption, which is consistent with our previous results
[2]. Regarding consumption of vitamin E, a lipid soluble
free radical scavenger, we did not observe any statistically
significantly differences between cases and controls,
although total dietary antioxidant index was statistically
significantly inversely associated with glioma in this
study. However, since results from other studies regarding
the roles of vitamin's C and E with brain tumor risk are
inconsistent [1,3,28-30], the roles of antioxidant vitamins
C & E may remain unclear. If the findings of inverse asso-
ciations of total antioxidant intake from all fruits, vegeta-
bles, juices and teas with glioma are replicated it may
Table 5: Summary of significant findings for odds ratios among self-reported glioma cases versus controls by quartiles of daily nutrient 
intake adjusted for age, gender, ethnicity, SES*, total calories**, and supplement use; San Francisco Bay Area Adult Glioma Study, 
1991–2000.†
Nutri-
ent 
Quartil
e2
Combined Series I & II1 Series I (1991–1995) Series II (1996–2000)
OR 95% CI3 p4 OR 95% CI3 p4 OR 95% CI3 p4
Antioxi
dant 
Index
1st 1 -- -- 0.06 1 -- -- 0.03 1 -- -- 0.51
2nd 1.08 0.78 1.48 1.06 0.68 1.67 1.05 0.66 1.67
3rd 1.01 0.73 1.40 0.90 0.56 1.44 1.11 0.70 1.76
4th 0.68 0.47 0.99 0.56 0.33 0.96 0.79 0.47 1.33
Carote
noids5
1st 1 -- -- 0.23 1 -- -- 0.31 1 -- -- 0.44
2nd 0.71 0.51 0.97 0.62 0.39 0.98 0.79 0.51 1.24
3rd 0.91 0.66 1.25 0.81 0.51 1.29 0.98 0.63 1.54
4th 0.74 0.52 1.05 0.71 0.43 1.16 0.76 0.46 1.24
β-
Carote
ne
1st 1 -- -- 0.54 1 -- -- 0.45 1 -- -- 0.85
2nd 0.77 0.56 1.07 0.61 0.38 0.98 0.96 0.61 1.50
3rd 0.87 0.63 1.21 0.78 0.49 1.24 0.96 0.60 1.53
4th 0.87 0.61 1.23 0.78 0.47 1.28 0.95 0.59 1.55
Daidzei
n
1st 1 -- -- 0.06 1 -- -- 0.99 1 -- -- 0.01
2nd 0.73 0.53 1.01 0.86 0.54 1.38 0.66 0.42 1.04
3rd 0.67 0.48 0.93 0.76 0.47 1.23 0.62 0.38 0.99
4th 0.74 0.53 1.04 1.06 0.64 1.77 0.55 0.34 0.89
Mataire
sinol
1st 1 -- -- 0.32 1 -- -- 0.11 1 -- -- 0.82
2nd 0.82 0.59 1.13 0.65 0.41 1.03 1.04 0.66 1.63
3rd 1.02 0.74 1.41 1.00 0.64 1.57 1.04 0.65 1.66
4th 0.76 0.53 1.09 0.53 0.31 0.90 1.06 0.64 1.75
*Categories for socio-economic status (SES) combine highest education attained and/or household income range. **Total calories = ln(total 
calories). †Case-control distributions (= N) for quartiles of nutrient consumption are provided in supplemental table 1 [see Additional file 1]. 1Also 
adjusted for study series. 2Quartile cutpoints were calculated from series- and gender-specific nutrient intake distributions among controls. 3CI = 
Confidence interval. 4 p-value for chi-square test for trend. 5 alpha- and beta-Carotene. Note: Boxed values are statistically significant odds ratios 
(with corresponding 95% confidence intervals that exclude 1.00) or tests for trend.BMC Cancer 2006, 6:148 http://www.biomedcentral.com/1471-2407/6/148
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suggest a protective role of these compounds for adult gli-
oma.
For carotenoid consumption, more consistent results have
been observed among studies of brain tumor risk. We
observed an inverse association of carotenoid consump-
tion with glioma risk, which is consistent with other stud-
ies [3,28] including a recent study in Nebraska, which
showed a two-fold reduction in risk of glioma with
increased carotenoid intake [4]. Carotenoids are
lipophilic molecules with antioxidant properties impli-
cated in scavenging peroxynitrite, modulating DNA repair
[31], and possibly anti-inflammatory mechanisms [32-
35].
We observed statistically significant inverse associations
for consumption of several phytoestrogens suggesting
protective effects. The most consistently significant
inverse association was observed for daidzein. Our results
also suggest protective effects against gliomas for for-
mononetin, matairesinol, secoisolariciresinol, and cou-
mestrol. Vaya and colleagues [36] showed that flavonoids,
which include isoflavones and coumestans, inhibit low
density lipoprotein oxidation. More specifically, mecha-
nistic studies suggest that flavonoids may down-regulate
both the expression of iNOS and cyclooxygenase-2 (COX-
2), both of which have pro-inflammatory roles [37-39].
Epidemiologic findings also support a role for inflamma-
tory and immune mediators in brain tumors. An inverse
association of brain tumors with asthma and autoim-
mune disease has been observed [10,40], which might
partly be related to an inverse association of non-steroidal
anti-inflammatory drug (NSAID) use or other anti-
inflammatory drugs [41].
Furthermore, the influence of phytoestrogens on pro-
inflammatory mediators may be a result of estrogen recep-
tor-dependent activities. Recent evidence from several
studies supports that estrogen receptors, and especially
estrogen receptor-beta, down-regulates iNOS and COX-2
gene expression [5,6]. Interestingly, expression of estro-
gen receptor-beta has been characterized in astrocytic
tumors, showing that as tumor grade increases, estrogen
receptor-beta expression decreases [7]. Furthermore, Hara
and Okayasu recently showed a strong correlation of vas-
cular endothelial growth factor (VEGF) and COX-2
expression, likely due to increased iNOS expression, with
degree of angiogenesis in astrocytomas [42]. Could phy-
toestrogen intake play a role in preventing the progression
of astrocytic tumors from low to high grade through estro-
gen receptor-dependent down-regulation of pro-inflam-
matory and pro-angiogenic mediators? Further studies of
phytoestrogen intake and astrocytic tumors are necessary
to clarify the suggestive association.
Conclusion
The observed inverse associations suggest a protective role
against gliomagenesis for consumption of foods rich in
antioxidants and certain phytoestrogens, especially daid-
zein. In light of the growing evidence supporting a role for
oxidative stress in gliomagenesis, future studies in brain
tumor research should focus on reactive nitrogen and oxy-
gen species to further clarify their roles as well as identify-
ing targets of treatment and prevention of glioma.
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